ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
121.802,06
-0,19%
S&P 500
5.291,34
0,15%
US Dollar vs BRL
5,2892
0,00%
Bitcoin
70.983,08
0,51%
Brent Oil
77,415
0,40%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. Capstone Therapeutics Corporation (QB) (CAPS)

  7. Capstone Therapeutics Corporation (QB) (CAPS) Notícias

CAPS

Capstone Therapeutics (QB) (CAPS)

Capstone Therapeutics Corporation (QB)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:CAPS
DataHoraFonteTítuloCódigoCompanhia
25/09/201917:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:CAPSCapstone Therapeutics Corporation (QB)
09/09/201910:02Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
26/08/201917:00Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
20/08/201918:25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
13/08/201910:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CAPSCapstone Therapeutics Corporation (QB)
10/07/201917:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
03/07/201915:41Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
31/05/201917:48Edgar (US Regulatory)Statement of Ownership: Private Transaction (sc 13e3)USOTC:CAPSCapstone Therapeutics Corporation (QB)
31/05/201917:04Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
22/03/201917:04Edgar (US Regulatory)Annual Report (10-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
21/03/201910:03Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:CAPSCapstone Therapeutics Corporation (QB)
13/02/201919:46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
11/02/201916:02Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CAPSCapstone Therapeutics Corporation (QB)
04/02/201918:53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CAPSCapstone Therapeutics Corporation (QB)
28/12/201815:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CAPSCapstone Therapeutics Corporation (QB)
30/10/201718:03Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
24/07/201718:11Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:CAPSCapstone Therapeutics Corporation (QB)
17/07/201718:09Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:CAPSCapstone Therapeutics Corporation (QB)
19/04/201710:01Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)USOTC:CAPSCapstone Therapeutics Corporation (QB)
16/09/201510:04Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
26/06/201516:50Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:CAPSCapstone Therapeutics Corporation (QB)
23/06/201516:10Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:CAPSCapstone Therapeutics Corporation (QB)
27/04/201516:46InvestorsHub NewsWireEDISON EQUITY RESEARCH - CAPSTONE THERAPEUTICSUSOTC:CAPSCapstone Therapeutics Corporation (QB)
24/06/201412:37Edgar (US Regulatory)Amended Securities Registration (section 12(g)) (8-a12g/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
24/06/201411:01Edgar (US Regulatory)(25)USOTC:CAPSCapstone Therapeutics Corporation (QB)
11/06/201413:47GlobeNewswire Inc.Capstone Therapeutics Announces Initiation of Dosing for AEM-28 Phase 1b/2a Human Clinical Trial in Refractory Hypercholester...USOTC:CAPSCapstone Therapeutics Corporation (QB)
16/05/201414:00GlobeNewswire Inc.Capstone Therapeutics Announces Operating Update Conference CallUSOTC:CAPSCapstone Therapeutics Corporation (QB)
08/04/201410:00GlobeNewswire Inc.Capstone Therapeutics Announces Initiation of Dosing for AEM-28 Phase 1 Human Clinical Trial in LDL/non-HDL Cholesterol Reduc...USOTC:CAPSCapstone Therapeutics Corporation (QB)
27/03/201410:02Edgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)USOTC:CAPSCapstone Therapeutics Corporation (QB)
27/03/201410:02Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
 Apresentando as notícias mais relevantes sobre:USOTC:CAPS

Seu Histórico Recente

TSXV
CANB
Canadabis Capital
COIN
TRGETH
The Rug Game
BIT
P1VMJ3
NLBNPIT1VMJ3 20991231 3....
BITMOT
2833989
Belgium Fx 3.5% Jun55 Eur
BIT
I07263
INTESA SANPAOLO
BIT
F33213
Vontobel Financial Produ...
BIT
XLYS
Invesco Consumer Discret...
BIT
UNIR
Unieuro
BIT
FRCP
Franklin MSCI China Pari...
USOTC
SOLCF
Sol Global Investments (PK)
BIT
F13900
Vontobel Financial Produ...
NASDAQ
CVCO
Cavco Industries
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados